Amphastar Pharmaceuticals, Inc.Amphastar Pharmaceuticals, Inc.Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

59.000.000.00%
The 4 analysts offering 1 year price forecasts for AMPH have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to AMPH in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


AMPH EPS for the last quarter is 0.96 USD despite the estimation of 0.99 USD. In the next quarter EPS is expected to reach 0.97 USD. Track more of Amphastar Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Amphastar Pharmaceuticals, Inc. revenue is expected to reach ‪192.69 M‬ USD. Check out Amphastar Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, AMPH price target is 59.00 USD with a max estimate of 66.00 USD and a min estimate of 55.00 USD. Check if this forecast comes true in a year, meanwhile watch Amphastar Pharmaceuticals, Inc. stock price chart and keep track of the current situation with AMPH news and stock market news.
We've gathered opinions of 5 analysts rating AMPH stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.